
Sign up to save your podcasts
Or


Join Dr Chari as he reviews the rationale and clinical evidence of novel non-BCMA-targeted bispecific antibodies for patients with R/R multiple myeloma.
Credit available for this activity expires: 6/10/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952772?src=mkm_podcast_addon_952772
By Medscape Podcasts4
77 ratings
Join Dr Chari as he reviews the rationale and clinical evidence of novel non-BCMA-targeted bispecific antibodies for patients with R/R multiple myeloma.
Credit available for this activity expires: 6/10/2022
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952772?src=mkm_podcast_addon_952772

1,263 Listeners

319 Listeners

506 Listeners

298 Listeners

1,396 Listeners

145 Listeners

895 Listeners

14 Listeners

16 Listeners

299 Listeners

3,360 Listeners

7,995 Listeners

197 Listeners

517 Listeners

373 Listeners

61 Listeners

28 Listeners

439 Listeners